TR201714882A2 - Topical pharmaceutical compositions of luliconazole - Google Patents

Topical pharmaceutical compositions of luliconazole Download PDF

Info

Publication number
TR201714882A2
TR201714882A2 TR2017/14882A TR201714882A TR201714882A2 TR 201714882 A2 TR201714882 A2 TR 201714882A2 TR 2017/14882 A TR2017/14882 A TR 2017/14882A TR 201714882 A TR201714882 A TR 201714882A TR 201714882 A2 TR201714882 A2 TR 201714882A2
Authority
TR
Turkey
Prior art keywords
luliconazole
pharmaceutical compositions
topical pharmaceutical
pharmaceutically acceptable
polymorphs
Prior art date
Application number
TR2017/14882A
Other languages
Turkish (tr)
Inventor
Ulusoy Bozyel Müge
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/14882A priority Critical patent/TR201714882A2/en
Priority to PCT/TR2018/050542 priority patent/WO2019070221A1/en
Publication of TR201714882A2 publication Critical patent/TR201714882A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to topical pharmaceutical compositions, comprising luliconazole or pharmaceutically acceptable salts, polymorphs, stereoisomers, solvates, hydrates or esters thereof and at least one pharmaceutically acceptable excipient.
TR2017/14882A 2017-10-03 2017-10-03 Topical pharmaceutical compositions of luliconazole TR201714882A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/14882A TR201714882A2 (en) 2017-10-03 2017-10-03 Topical pharmaceutical compositions of luliconazole
PCT/TR2018/050542 WO2019070221A1 (en) 2017-10-03 2018-10-02 Topical pharmaceutical compositions of luliconazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/14882A TR201714882A2 (en) 2017-10-03 2017-10-03 Topical pharmaceutical compositions of luliconazole

Publications (1)

Publication Number Publication Date
TR201714882A2 true TR201714882A2 (en) 2019-04-22

Family

ID=65276258

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/14882A TR201714882A2 (en) 2017-10-03 2017-10-03 Topical pharmaceutical compositions of luliconazole

Country Status (2)

Country Link
TR (1) TR201714882A2 (en)
WO (1) WO2019070221A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114259462A (en) * 2021-12-13 2022-04-01 海南海灵化学制药有限公司 External cream composition containing luliconazole
JP2025066191A (en) * 2022-01-19 2025-04-23 日本農薬株式会社 Antifungal eye drops

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692045A5 (en) 1995-07-08 2002-01-15 Nihon Nohyaku Co Ltd Fungicidal agents, a compound therefor, process for their preparation and methods for their use.
EP2025337B1 (en) 2006-03-08 2014-09-10 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
CA2645070C (en) 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
CN101820877B (en) * 2007-08-27 2013-09-11 日本农药株式会社 Agent for fungal dermatitis
JP5941909B2 (en) * 2011-04-27 2016-06-29 マルホ株式会社 Suspension lotion containing imidazole antifungal
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP5589110B1 (en) * 2013-03-08 2014-09-10 株式会社ポーラファルマ Crystal having crystal habit and pharmaceutical composition containing the crystal as an active ingredient
CN105263525A (en) * 2013-04-12 2016-01-20 维奥姆生物科学有限公司 Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections

Also Published As

Publication number Publication date
WO2019070221A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
ZA201606320B (en) Human plasma kallikrein inhibitors
MY190835A (en) Bicyclic heterrocyclic derivatives as bromodomain inhibitors
SG10201811384TA (en) Mnk inhibitors and methods related thereto
MX2020010690A (en) Oxysterols and methods of use thereof.
MA39956A (en) Benzomorphan analogs and use thereof
MX2016013431A (en) Pharmaceutical compositions comprising antibacterial agents.
TN2016000489A1 (en) Carboxamide derivatives.
TR201721505A2 (en) The combination comprising linagliptin and metformin
TR201714882A2 (en) Topical pharmaceutical compositions of luliconazole
IN2013MU00665A (en)
MX2017014301A (en) Compositions and methods for the treatment or prevention of pulmonary hypertension.
PH12017501736B1 (en) Indole derivatives
IN2014MU00859A (en)
MX2017002544A (en) Isoquinolinone derivatives useful in the treatment of cancer.
WO2019004980A3 (en) Solid oral pharmaceutical compositions of dabigatran etexilate
IN2013MU03308A (en)
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2016013428A (en) Pharmaceutical compositions comprising antibacterial agents.
IN2013MU03309A (en)
IN2013MU03421A (en)
MX2016005539A (en) Pharmaceutical compositions comprising antibacterial agents.
MX2018010652A (en) Pharmaceutical compositions.
MX2017010992A (en) Stable pharmaceutical compositions comprising antibacterial agent.
IN2014MU01194A (en)
PH12020500385A1 (en) A process for preparation of triaminopyrimidine compound and intermediates thereof